We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Digital CZT Detectors Developed for Pre-clinical Imaging

By Biotechdaily staff writers
Posted on 11 Oct 2007
New digital cadmium zinc telluride (CZT) detectors for nuclear imaging applications have advantages over photomultiplier tube- (PMT)-based detectors, including that of increased sensitivity.

Gamma Medica-Ideas, Inc. More...
(GM-I; Oslo, Norway), a developer of digital medical imaging devices for the pre-clinical and clinical markets, has recently developed digital cadmium zinc telluride (CZT) detectors for nuclear imaging. The Oklahoma Medical Research Foundation (OMRF; Oklahoma City, OK, USA) installed the detectors in a dual-modality single photon emission tomography/computed tomography (SPECT/CT) configuration for pre-clinical imaging.

Dr. Rheal Towner, director of the MRI (Magnetic Resonance Imaging) Facility for the Free Radical Biology & Aging Research Program at OMRF, reported that GM-I's digital CZT detectors offer strong advantages over photomultiplier tube (PMT)-based detectors. "Gamma Medica-Ideas' state-of-the-art digital CZT detectors allow OMRF to benefit from increased sensitivity, which traditional PMT-based detectors cannot provide,” said Dr. Towner.

Oklahoma Medical Research Foundation's main research efforts are grouped into three major areas: cancer research, neurologic disease research, and cardiovascular disease research. Gamma Medica-Ideas' Flex system currently installed in OMRF's Small Animal Imaging Facility is used principally to look at metastases in animal cancer models, study metastases in lungs and design molecular targeted agents.

"Digital detection systems for nuclear medicine will soon make analog photomultiplier tube-based systems obsolete in the same way that digital mobile phones replaced analog cellular and digital technology has taken over analog in every audio/video market. It's more efficient, more reliable, and vastly better technology. With digital technology everything is better--performance, maintenance, and upgrading,” said Gamma Medica-Ideas president and CEO, Dr. Bradley Patt.

Gamma Medica-Ideas' Flex pre-clinical system, recently upgraded to the Flex Triumph multi-modality pre-clinical platform, provides multiple configurations to meet user needs. It can combine up to three different imaging modalities (PET [positron emission tomography], SPECT, and CT) in a single platform. Major application areas include cardiology, neurology, oncology, and bone analysis.


Related Links:
Gamma Medica-Ideas
Oklahoma Medical Research Foundation

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.